| scholarly article | Q13442814 |
| P50 | author | Neal L Weintraub | Q61186977 |
| P2093 | author name string | David Y Hui | |
| Kan Hui Yiew | |||
| Tapan K Chatterjee | |||
| Joshua E Basford | |||
| David W Stepp | |||
| P2860 | cites work | HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high-fat feeding | Q37403326 |
| Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor | Q37423469 | ||
| The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism | Q37521189 | ||
| Weighing in on adipocyte precursors | Q37625887 | ||
| Epigenetic programming and reprogramming during development | Q38086774 | ||
| Adipose tissue dysfunction contributes to obesity related metabolic diseases | Q38111530 | ||
| Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. | Q39696350 | ||
| FGF21 mediates the lipid metabolism response to amino acid starvation. | Q42034608 | ||
| FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology | Q42176870 | ||
| Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. | Q42972684 | ||
| Depot-specific differences in adipogenic progenitor abundance and proliferative response to high-fat diet | Q43297876 | ||
| Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. | Q45265401 | ||
| Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis | Q45371799 | ||
| The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes | Q45834496 | ||
| Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. | Q47313505 | ||
| Functional thermogenic beige adipogenesis is inducible in human neck fat. | Q50937141 | ||
| Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex. | Q54468633 | ||
| Adipose tissue inflammation: are small or large fat cells to blame? | Q84949381 | ||
| Brown and white fat: from signaling to disease | Q86549135 | ||
| Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation | Q24307379 | ||
| A role of DNA-PK for the metabolic gene regulation in response to insulin | Q24323112 | ||
| MEF-2 function is modified by a novel co-repressor, MITR | Q24534397 | ||
| Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor | Q28140525 | ||
| The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis | Q28513025 | ||
| Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke | Q29417129 | ||
| Cold-activated brown adipose tissue in healthy men | Q29547382 | ||
| Dynamics of fat cell turnover in humans | Q29615688 | ||
| Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat. | Q33762194 | ||
| Tracking adipogenesis during white adipose tissue development, expansion and regeneration | Q33824485 | ||
| Brown adipose tissue in morbidly obese subjects | Q33842257 | ||
| Rapid cellular turnover in adipose tissue | Q33847015 | ||
| High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma. | Q33966440 | ||
| Identification of an adipogenic niche for adipose tissue remodeling and restoration | Q34289690 | ||
| Adaptive thermogenesis in adipocytes: is beige the new brown? | Q34326605 | ||
| Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein. | Q34385667 | ||
| Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. | Q34390824 | ||
| Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells | Q34503302 | ||
| Myocyte enhancer factor-2 interacting transcriptional repressor (MITR) is a switch that promotes osteogenesis and inhibits adipogenesis of mesenchymal stem cells by inactivating peroxisome proliferator-activated receptor gamma-2. | Q34695969 | ||
| Histone deacetylase 9 is a negative regulator of adipogenic differentiation | Q35145068 | ||
| Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells. | Q35300659 | ||
| Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity | Q35309505 | ||
| Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9 | Q35405305 | ||
| FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis | Q35755169 | ||
| In vivo identification of bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat feeding | Q35878325 | ||
| Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases | Q36141408 | ||
| Secretory factors from human adipose tissue and their functional role | Q36165333 | ||
| Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue | Q36635336 | ||
| Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat. | Q36758223 | ||
| Brown fat activation mediates cold-induced thermogenesis in adult humans in response to a mild decrease in ambient temperature | Q36981957 | ||
| Fat cells directly sense temperature to activate thermogenesis | Q37049421 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 333-338 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Adipocyte | Q26853830 |
| P1476 | title | Role of histone deacetylase 9 in regulating adipogenic differentiation and high fat diet-induced metabolic disease | |
| P478 | volume | 3 |
| Q42802504 | A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity |
| Q94601791 | Concise Review: The Regulatory Mechanism of Lysine Acetylation in Mesenchymal Stem Cell Differentiation |
| Q54997679 | Emerging roles for histone deacetylases in age-related muscle atrophy. |
| Q28078472 | Gender Differences in Adipocyte Metabolism and Liver Cancer Progression |
| Q58792327 | HDAC11 suppresses the thermogenic program of adipose tissue via BRD2 |
| Q94454420 | Histone Deacetylase 9: Its Role in the Pathogenesis of Diabetes and Other Chronic Diseases |
| Q33755017 | Melatonin and Vitamin D Interfere with the Adipogenic Fate of Adipose-Derived Stem Cells |
| Q89353095 | Programming and Regulation of Metabolic Homeostasis by HDAC11 |
| Q42165518 | Regeneration of fat cells from myofibroblasts during wound healing. |
| Q37260645 | Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy |
| Q57153351 | The Epigenetics of Metabolic Syndrome |
Search more.